Information on Ipratropium and Albuterol

The ipratropium and albuterol inhaler (Combivent®) is used to treat chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. However, it will not be available in its current form much longer. This product contains chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer; it will not be made, dispensed, or sold in the United States in its current form after December 31, 2013. The manufacturer is working on a reformulated, CFC-free version that is set to be available to consumers by the time the old formulation is phased out.
 
(For more information, click Ipratropium and Albuterol Inhaler. Topics discussed in this article include dosing guidelines, potential side effects, and safety issues to be aware of while using this drug.)
 

Information on Ipratropium and Albuterol

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.